Language selection

Search

2014-11-20 - Male - 74 Years old

632510

Adverse reaction report number 632510
Latest AER version number 0
Market authorization holder AER number N/A
Initial received date 2014-11-20
Latest received date 2014-11-20
Age 74 Years
Gender Male
Weight N/A
Type of report Spontaneous
Reporter type Physician
Source of report Community
Report outcome Recovered/resolved
Serious report? Yes

Reason for seriousness

Death
Disability
Cogenital anomaly
Life threateting
Hospitalization
Other medically important Yes

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XR 20MGCAPSULE, EXTENDED RELEASESuspectOral20 Milligram1 every 1 Day(s)158 Day(s)Attention deficit/hyperactivity disorder
CLONIDINENOT SPECIFIEDConcomitant

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Drooling
Dysarthria
Jaw disorder
Tardive dyskinesia
Date modified: